A 21-year-old woman from eMbalenhle became the first person in South Africa to receive Lenacapavir, a groundbreaking long-acting HIV prevention injection poised to reshape national prevention efforts.
Jane Mndebele volunteered this morning (June 5) at the Extension19 Clinic in eMbalenhle to receive this pioneering HIV prevention medication, marking a defining moment in the country’s public health journey.
This kicked off the national rollout of Lenacapavir. The office of the Mpumalanga Premier, Mandla Ndlovu, issued a media release, lauding this historic event as positioning the province at the forefront of a major advancement in HIV prevention and offering renewed hope in reducing new infections nationwide.
This landmark development highlights South Africa’s commitment to innovative healthcare solutions, with Mpumalanga leading the way in introducing next-generation HIV prevention tools aimed at strengthening community health and curbing the spread of HIV/AIDS.
President Cyril Ramaphosa and Minister of Health, Dr Aaron Motsoaledi, led the rollout.
ALSO CHECK: WATCH: President speaks in Secunda at launch of new HIV injection rollout
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Support local journalism
Add The Citizen as a preferred source to see more from Ridge Times in Google News and Top Stories.
Themba Vukeya
www.citizen.co.za
